143 related articles for article (PubMed ID: 33108070)
1. Analysis of expression levels of markers associated with tumor proliferation and angiogenesis in familial adenomatous polyposis.
Zhang Z; Wang D; Xu C; Li Y; Yu Y; Chen C; Li M; Zhang X
Mol Genet Genomic Med; 2020 Dec; 8(12):e1534. PubMed ID: 33108070
[TBL] [Abstract][Full Text] [Related]
2. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC;
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247
[TBL] [Abstract][Full Text] [Related]
3. Estrogen Receptor β as a Prognostic Marker of Tumor Progression in Colorectal Cancer with Familial Adenomatous Polyposis and Sporadic Polyps.
Stevanato Filho PR; Aguiar Júnior S; Begnami MD; Ferreira FO; Nakagawa WT; Spencer RMSB; Bezerra TS; Boggiss PE; Lopes A
Pathol Oncol Res; 2018 Jul; 24(3):533-540. PubMed ID: 28681123
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin expression is homogeneously reduced in adenoma from patients with familial adenomatous polyposis: an immunohistochemical study of E-cadherin, beta-catenin and cyclooxygenase-2 expression.
Jungck M; Grünhage F; Spengler U; Dernac A; Mathiak M; Caspari R; Friedl W; Sauerbruch T
Int J Colorectal Dis; 2004 Sep; 19(5):438-45. PubMed ID: 14986031
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia.
Delker DA; Wood AC; Snow AK; Samadder NJ; Samowitz WS; Affolter KE; Boucher KM; Pappas LM; Stijleman IJ; Kanth P; Byrne KR; Burt RW; Bernard PS; Neklason DW
Cancer Prev Res (Phila); 2018 Jan; 11(1):4-15. PubMed ID: 29109117
[TBL] [Abstract][Full Text] [Related]
6. Epithelial turnover in duodenal familial adenomatous polyposis: A possible role for estrogen receptors?
Di Leo A; Nesi G; Principi M; Piscitelli D; Girardi B; Pricci M; Losurdo G; Iannone A; Ierardi E; Tonelli F
World J Gastroenterol; 2016 Mar; 22(11):3202-11. PubMed ID: 27003997
[TBL] [Abstract][Full Text] [Related]
7. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
[TBL] [Abstract][Full Text] [Related]
8. Expression of Notch-signaling pathway in familial adenomatous polyposis and its clinical significance.
Xie ZY; Gong LB; Zhang WT; Lv XP
Eur Rev Med Pharmacol Sci; 2014; 18(21):3183-8. PubMed ID: 25487926
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.
Kennedy BP; Soravia C; Moffat J; Xia L; Hiruki T; Collins S; Gallinger S; Bapat B
Cancer Res; 1998 Feb; 58(3):500-3. PubMed ID: 9458096
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of p53 in early colon polyps in a pig model of human familial adenomatous polyposis.
Sikorska A; Flisikowska T; Stachowiak M; Kind A; Schnieke A; Flisikowski K; Switonski M
J Appl Genet; 2018 Nov; 59(4):485-491. PubMed ID: 30145695
[TBL] [Abstract][Full Text] [Related]
11. Targeted next-generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis.
Wang D; Liang S; Zhang X; Dey SK; Li Y; Xu C; Yu Y; Li M; Zhao G; Zhang Z
Mol Genet Genomic Med; 2019 Jan; 7(1):e00505. PubMed ID: 30523670
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
[TBL] [Abstract][Full Text] [Related]
13. Comparison of dysplastic fundic gland polyps in patients with and without familial adenomatous polyposis.
Straub SF; Drage MG; Gonzalez RS
Histopathology; 2018 Jun; 72(7):1172-1179. PubMed ID: 29436014
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen receptor beta isoform expression in sporadic colorectal cancer, familial adenomatous polyposis and progressive stages of colorectal cancer.
Stevanato Filho PR; Aguiar Júnior S; Begnami MD; Kuasne H; Spencer RM; Nakagawa WT; Bezerra TS; Kupper BC; Takahashi RM; Barros Filho M; Rogatto SR; Lopes A
BMC Cancer; 2017 Nov; 17(1):754. PubMed ID: 29132333
[TBL] [Abstract][Full Text] [Related]
15. Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis.
Fornasarig M; Magris R; De Re V; Bidoli E; Canzonieri V; Maiero S; Viel A; Cannizzaro R
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882764
[TBL] [Abstract][Full Text] [Related]
16. The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome.
Li SZ; Zhao YB; Cao WD; Qu Y; Luo P; Zhen HN; Chen XY; Yan ZF; Fei Z
Med Oncol; 2013; 30(3):622. PubMed ID: 23771798
[TBL] [Abstract][Full Text] [Related]
17. Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients.
Sample DC; Samadder NJ; Pappas LM; Boucher KM; Samowitz WS; Berry T; Westover M; Nathan D; Kanth P; Byrne KR; Burt RW; Neklason DW
BMC Gastroenterol; 2018 Jul; 18(1):115. PubMed ID: 30012100
[TBL] [Abstract][Full Text] [Related]
18. Juvenile polyposis syndrome might be misdiagnosed as familial adenomatous polyposis: a case report and literature review.
Gao XH; Li J; Zhao ZY; Xu XD; Du YQ; Yan HL; Liu LJ; Bai CG; Zhang W
BMC Gastroenterol; 2020 Jun; 20(1):167. PubMed ID: 32487124
[TBL] [Abstract][Full Text] [Related]
19. Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.
Takane K; Matsusaka K; Ota S; Fukuyo M; Yue Y; Nishimura M; Sakai E; Matsushita K; Miyauchi H; Aburatani H; Nakatani Y; Takayama T; Matsubara H; Akagi K; Kaneda A
Oncotarget; 2016 Dec; 7(51):84003-84016. PubMed ID: 27563825
[TBL] [Abstract][Full Text] [Related]
20. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
